Fed. Cir.

Novartis AG v. Lee, No. 13-1160 (Fed. Cir. Jan. 15, 2014)

Errata

Court: U.S. Court of Appeals for the Federal Circuit
Case No.: No. 13-1160
Decided: January 15, 2014
Judge: —
Document: Errata
Length: 1 page

Full Text Analysis Cite this Opinion

Download Opinion (PDF)

United States Court of Appeals

for the Federal Circuit

April 16, 2014

ERRATA

Appeal Nos. 2013-1160, -1175, -1179

NOVARTIS AG AND

NOVARTIS VACCINES AND DIAGNOSTICS, INC.,

AND

DANA-FARBER CANCER INSTITUTE,

MICHELLE K. LEE, Deputy Director, United States Patent and Trademark Office,

Decided: January 15, 2014

Precedential Opinion

Please make the following changes: Page 2, line 24, change “otherwise-applicable term” to --otherwise-applicable terms--. Page 12, line 21, change “his own neglect” to --[its] own neglect--. Page 14, line 26, change “resulting extensions” to --resulting extension--.

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Novartis AG v. Lee, No. 13-1160 (Fed. Cir. Jan. 15, 2014).

govinfo ID: USCOURTS-ca13-13-01160-1
Permalink: https://patentcasewatch.com/opinions/USCOURTS-ca13-13-01160-1

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.

Source: govinfo.gov USCOURTS collection · retrieved July 25, 2026 · Report an error